Valuation: The ACME Laboratories Ltd.

Market Cap 17.44B 142M 123M 115M 105M 197M 13.59B 200M 1.35B 528M 6.8B 533M 522M 22.61B P/E 2024
5.9x
P/E 2025 6.29x
Enterprise Value 40.31B 328M 284M 267M 242M 456M 31.41B 463M 3.12B 1.22B 15.73B 1.23B 1.21B 52.27B EV / Sales 2024
1.15x
EV / Sales 2025 1.06x
Free-Float
51.84%
Yield 2024
5.11%
Yield 2025 4.85%
1 day+0.12%
1 week+0.60%
Current month-0.48%
1 month-4.15%
3 months+9.33%
6 months+9.19%
Current year+17.35%
1 week 82.2
Extreme 82.2
84.1
1 month 82
Extreme 82
86.5
Current year 70.6
Extreme 70.6
88.7
1 year 68.6
Extreme 68.6
88.7
3 years 62.6
Extreme 62.6
94.5
5 years 62.6
Extreme 62.6
117.7
10 years 54.2
Extreme 54.2
122.4
Manager TitleAgeSince
Chief Executive Officer 82 1995-09-29
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 82 1975-03-16
Director/Board Member 76 1981-04-14
Chairman 69 2018-09-04
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%+0.60%+3.10%-2.12% 143M
-2.25%-0.47%+72.43%+119.36% 1,052B
-0.66%+0.43%+49.01%+50.11% 627B
-0.54%+1.39%+21.88%+63.83% 441B
-1.99%-3.32%+41.98%+34.08% 349B
-1.05%-2.81%+24.22%+34.67% 287B
-2.12%-3.67%-1.09%+3.11% 241B
-0.63%+1.04%+43.03%+59.10% 224B
-1.19%-3.41%-9.18%-52.41% 202B
+0.16%+3.87%+16.25%+73.27% 172B
Average -0.58%+0.49%+26.16%+38.30% 359.53B
Weighted average by Cap. -0.09%+0.32%+41.31%+62.02%

Financials

2024 2025
Net sales 31.93B 260M 225M 211M 192M 361M 24.88B 367M 2.47B 967M 12.46B 977M 956M 41.4B 35.94B 293M 253M 238M 216M 406M 28B 413M 2.78B 1.09B 14.02B 1.1B 1.08B 46.6B
Net income 2.46B 20.01M 17.29M 16.24M 14.77M 27.77M 1.91B 28.23M 190M 74.41M 958M 75.14M 73.51M 3.18B 2.43B 19.79M 17.09M 16.06M 14.61M 27.46M 1.89B 27.91M 188M 73.58M 948M 74.3M 72.68M 3.15B
Net Debt 22.18B 181M 156M 147M 133M 251M 17.28B 255M 1.72B 672M 8.65B 679M 664M 28.76B 22.87B 186M 161M 151M 138M 259M 17.82B 263M 1.77B 693M 8.92B 700M 685M 29.66B
Logo The ACME Laboratories Ltd.
The ACME Laboratories Limited is a Bangladesh-based company, which is engaged in manufacturing, marketing, and distribution of pharmaceuticals formulation products. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products, which include human drugs comprising dosages like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, and sachet products. It also offers veterinary drugs comprising dosages like bolus, liquid, injection, water-soluble powder, premix, and herbal drugs comprising dosages like liquid, capsule, tablet, cream, and ointment. The products of the Company are sold in domestic and international markets, respectively. Its factory is situated at Dhulivita, Dhamrai, Dhaka, and Bangladesh. It produces approximately 800 products in different dosage forms.
Employees
9,025
Date Price Change Volume
26-08-13 BDT 83.20 +0.12% 120,440
26-08-12 BDT 83.10 -0.48% 232,817
26-08-11 BDT 83.50 +1.09% 237,546
26-08-10 BDT 82.60 +0.24% 99,135
26-08-09 BDT 82.40 -0.36% 150,907
  1. Stock Market
  2. Stocks
  3. ACMELAB Stock